Product NDC: | 0168-0407 |
Proprietary Name: | Ciclopirox |
Non Proprietary Name: | Ciclopirox |
Active Ingredient(s): | 7.7 mg/g & nbsp; Ciclopirox |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0407 |
Labeler Name: | E. Fougera & CO. a division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077896 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080610 |
Package NDC: | 0168-0407-99 |
Package Description: | 100 g in 1 TUBE (0168-0407-99) |
NDC Code | 0168-0407-99 |
Proprietary Name | Ciclopirox |
Package Description | 100 g in 1 TUBE (0168-0407-99) |
Product NDC | 0168-0407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciclopirox |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20080610 |
Marketing Category Name | ANDA |
Labeler Name | E. Fougera & CO. a division of Fougera Pharmaceuticals Inc. |
Substance Name | CICLOPIROX |
Strength Number | 7.7 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |